Dr. Glenn Davis, MD

NPI: 1568450757
Total Payments
$2.2M
2024 Payments
$443,602
Companies
7
Transactions
62

Payment Breakdown by Category

Royalty/License$2.2M (100.0%)
Food & Beverage$395.91 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $2.2M 52 100.0%
Food and Beverage $395.91 10 0.0%

Top Paying Companies

Company Total Records Latest Year
Affordable Pharmaceuticals, LLC $1.4M 33 $0 (2024)
Braintree Laboratories, Inc. $791,663 19 $0 (2024)
Novartis Pharmaceuticals Corporation $248.74 2 $0 (2018)
ABBVIE INC. $83.89 4 $0 (2022)
AstraZeneca Pharmaceuticals LP $30.31 2 $0 (2018)
Boston Scientific Corporation $19.32 1 $0 (2019)
Allergan Inc. $13.65 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $443,602 8 Affordable Pharmaceuticals, LLC ($285,690)
2023 $260,472 6 Affordable Pharmaceuticals, LLC ($131,317)
2022 $510,664 9 Affordable Pharmaceuticals, LLC ($336,232)
2021 $342,750 10 Affordable Pharmaceuticals, LLC ($212,412)
2020 $328,191 8 Braintree Laboratories, Inc. ($199,896)
2019 $129,267 7 Affordable Pharmaceuticals, LLC ($129,247)
2018 $80,078 7 Affordable Pharmaceuticals, LLC ($79,924)
2017 $125,169 7 Affordable Pharmaceuticals, LLC ($125,016)

All Payment Transactions

62 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/24/2024 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug) Royalty or License Cash or cash equivalent $46,433.93 General
Category: GI COLON PREP
10/24/2024 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $37,166.04 General
Category: GI COLON PREP
07/25/2024 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug) Royalty or License Cash or cash equivalent $98,297.46 General
Category: GI COLON PREP
07/25/2024 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $30,836.61 General
Category: GI COLON PREP
04/25/2024 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug) Royalty or License Cash or cash equivalent $80,859.51 General
Category: GI COLON PREP
04/25/2024 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $40,062.46 General
Category: GI COLON PREP
01/29/2024 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug) Royalty or License Cash or cash equivalent $60,099.21 General
Category: GI COLON PREP
01/29/2024 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $49,846.38 General
Category: GI COLON PREP
10/26/2023 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug) Royalty or License Cash or cash equivalent $47,118.56 General
Category: GI COLON PREP
10/26/2023 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $36,153.91 General
Category: GI COLON PREP
07/28/2023 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug) Royalty or License Cash or cash equivalent $38,167.55 General
Category: GI COLON PREP
07/26/2023 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $49,291.28 General
Category: GI COLON PREP
04/26/2023 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug), PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE, PEG-3350 AND ELECTROLYTES Royalty or License Cash or cash equivalent $46,030.53 General
Category: GI COLON PREP
04/26/2023 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $43,710.45 General
Category: GI COLON PREP
10/28/2022 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug), PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE, PEG-3350 AND ELECTROLYTES Royalty or License Cash or cash equivalent $161,675.17 General
Category: GI COLON PREP
10/28/2022 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $53,620.08 General
Category: GI COLON PREP
08/17/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.41 General
Category: NEUROSCIENCE
07/28/2022 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug), PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE, PEG-3350 AND ELECTROLYTES Royalty or License Cash or cash equivalent $67,628.49 General
Category: GI COLON PREP
07/28/2022 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $40,312.26 General
Category: GI COLON PREP
04/28/2022 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug), PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE, PEG-3350 AND ELECTROLYTES Royalty or License Cash or cash equivalent $66,989.01 General
Category: GI COLON PREP
04/28/2022 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $44,571.95 General
Category: GI COLON PREP
01/27/2022 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug), PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE, PEG-3350 AND ELECTROLYTES Royalty or License Cash or cash equivalent $39,939.64 General
Category: GI COLON PREP
01/27/2022 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $35,903.27 General
Category: GI COLON PREP
10/28/2021 Affordable Pharmaceuticals, LLC PEG-3350 AND ELECTROLYTES (Drug), PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE, PEG-3350 AND ELECTROLYTES Royalty or License Cash or cash equivalent $60,136.11 General
Category: GI COLON PREP
10/28/2021 Braintree Laboratories, Inc. GOLYTELY (Drug) Royalty or License Cash or cash equivalent $37,785.79 General
Category: GI COLON PREP

About Dr. Glenn Davis, MD

Dr. Glenn Davis, MD is a Gastroenterology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568450757.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Davis, MD has received a total of $2.2M in payments from pharmaceutical and medical device companies, with $443,602 received in 2024. These payments were reported across 62 transactions from 7 companies. The most common payment nature is "Royalty or License" ($2.2M).

Practice Information

  • Specialty Gastroenterology
  • Location Little Rock, AR
  • Active Since 10/11/2005
  • Last Updated 07/30/2007
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1568450757

Products in Payments

  • PEG-3350 AND ELECTROLYTES (Drug) $1.4M
  • GOLYTELY (Drug) $591,767
  • PEG3350 w/ELECTROLYTES (Drug) $204,940
  • ENTRESTO (Drug) $248.74
  • VRAYLAR (Drug) $69.41
  • FARXIGA (Drug) $30.31
  • WATCHMAN (Device) $19.32
  • Humira (Biological) $14.48
  • VIBERZI (Drug) $13.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Little Rock